Want to join the conversation?
$JNJ said that its estimated free cash flow for FY15 was at $15.9Bil, an increase of $1.1Bil compared to last year. In the company's Consumer segment, results outside the US were driven by strong sales of upper respiratory products and relaunch of anti-smoking products, while in the Pharmaceutical segment, sales outside the US fell approx. 0.2%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?